Use of antiepileptic drugs in a community-dwelling Dutch population

Neurology

Volumn 46, Issue 1, 1996, Pages 62-67

  Lammers, M W ^a   Hekster, Y A ^a   Keyser, A ^a   Meinardi, H ^a,c   Renier, W O ^a   Herings, R M C ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; MESUXIMIDE; METHYLPHENOBARBITAL; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CHILD; COMBINATION CHEMOTHERAPY; EPILEPSY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTPATIENT CARE; POLICY; PRESCRIPTION; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

EID: 0029993278     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.1.62     Document Type: Article

References (22)

1. Wijsman DJP, Lammers MW, Hekster YA, et al. Epilepsy treatment in The Netherlands. Comparison of two medical centres. Acta Neurol Scand 1993; 87:438-442.
2. Lammers MW, Hekster YA, Keyser A, et al. Epilepsy treatment in The Netherlands. Comparison of matched groups of two medical centres. Acta Neurol Scand 1994; 89:415-420.
3. Bongers E, Coppoolse J, Meinardi H, Posthuma EPS, van Zijl CHW. A survey of epilepsy in Zeeland, The Netherlands. Heemstede: Instituut voor Epilepsiebestrijding, 1976.
4. Voorn ThB. Chronische ziekten in de huisartspraktijk [thesis]. Nijmegen, The Netherlands, 1983.
5. Rutgers MJ. Geneeskundige en maatschappelijke aspecten van de zorg voor epilepsiepatiënten in Nederland [thesis]. Rotterdam, The Netherlands, 1984.
6. Lapperre-Regelink M, Aben DJM, Höppener RJEA. Analyse van de gezondheidssituatie in het verzorgingsgebied van de GGD regio Geldrop-Valkenswaard. Bouwstenen voor gezondheidsbeleid 1986, 1. Valkenswaard: GGD, 1988.
7. Crobach MJJS, Niezink GM, van der Leden J, Springer MP. Epilepsie en huisarts: toeval of hoofdzaak? Ned Tijdschr Geneeskd 1988; 132:1888-1892.
8. Wuis EW, Hekster YA, Zuidgeest LJB, de Goede WJ, Hommes OR, Keyser A. Drug utilization patterns of antiepileptic drugs in a University Hospital. J Soc Admin Pharmacy 1985; 3:59-63.
9. Herings RMC. PHARMO. A record linkage system for post-marketing surveillance of prescription drugs in The Netherlands [thesis]. Utrecht, The Netherlands, 1993.
10. WHO Collaborating Center for Drugs Statistics Methodology and Nordic Council on Medicines. Guidelines for DDD. Oslo, 1991.
11. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991; 32:429-445.
12. Centraal Bureau voor de Statistiek, Leeftijdsopbouw per gemeente op 1 januari 1992, kerncijfers, Voorburg/Heerlen, 1993.
13. de la Court A, Breteler MMB, Meinardi H, Hauser WA, Hofman A. Prevalence of epilepsy in the elderly. The Rotterdam Study (submitted for publication).
14. Reynolds EH, Shorvon SD. Monotherapy or polytherapy for epilepsy? Epilepsia 1981; 22:1-10.
15. Lloyd Jones A. Medical audit of the care of patients with epilepsy in one group practice. J R Coll Gen Practit 1980; 30:396-400.
16. Goodridge DMG, Shorvon SD. Epileptic seizures in a population of 6000. II: Treatment and prognosis. BMJ 1983; 287: 645-647.
17. McCluggage JR, Ramsey HC, Irwin WG, Dowds MF. Anticonvulsant therapy in a general practice population in Northern Ireland. J R Coll Gen Practit 1984; 34:24-31.
18. Cooper GL, Huitson A. An audit of the management of patients with epilepsy in thirty general practices. J R Coll Gen Practit 1986; 36:204-208.
19. Remy C, Dellatolas G, Genton P, Vespignani H. Monothérapie versus polythérapie: habitudes thérapeutiques dans l'épilepsie. (Résultats d'une étude transversale effectuée en 1988 dans trois centres français). Epilepsies 1992; 4:61-66.
20. Houtkooper MA, Lammertsma A, Meyer JWA, et al. Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine? Epilepsia 1987; 28:693-698.
21. Reinikainen KJ, Keränen T, Halonen T, Komulainen H, Riekkinen PJ. Comparison of oxcarbazepine and carbamazepine: a double-blind study. Epilepsy Res 1987; 1:284-289.
22. Grant SM, Faulds D. Oxcarbazepine: a review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 1992; 43:873-888.